TB796

N/A

Report date: 2024/08/26 10:53:05

First In Class

Base Information

Drug NameTB796

Drug Alias NameTB796TB-796

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)

Mechanisms of ActionInsulin-like growth factor I modulators

TargetsInsulin-like growth factor I

Therapy Area/IndicationsSarcopenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTwinpig Biolab Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSarcopenia

Inactive IndicationsN/A

ATC CodeN/A